HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen

HIV-DNA, CD32a CD4+ T-cells and immune activation on successfull dolutegravir-based regimen

Bibliographic Details
Main Authors:	P. Gantner, M. Partisani, C. Barnig, G. Beck-Wirth, J.P. Faller, M. Artinot, M. Mohseni-Zadeh, C. Cheneau, M.L. Batard, A. Fuchs, P. Fischer, S. Bahram, D. Rey, S. Fafi-Kremer
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S205566402030621X

Similar Items

Spread of HIV-DNA in CD4+ T-cells subsets depends on ART initiation timing
by: P. Gantner, et al.
Published: (2017-12-01)

THE STUDY OF THE SUCCESSFULL FACTORS FOR THE LISTED COMPANIES IN TAIWAN
by: HSIEH, TZU-WEN, et al.
Published: (1996)

Facing 2020: the 9 traits of successfull migrant entrepreneurs in the municipality of rome
by: Valentina Cillo, et al.
Published: (2014-09-01)

HYDRODINAMICS AND SWIMMING TEHNIQUE AS PARAMETERS FOR SUCCESSFULL SWIMMING AT THE AGE 10–12
by: Goran Dimitrić, et al.
Published: (2008-08-01)

How do you cue? : self-generated retrieval cues and successfull recall
by: Mäntylä, Timo
Published: (1986)

Successfull simultaneous pancreas kidney transplantation in a patient with congenital partial lipodystrophy
by: Luis Leon, et al.
Published: (2016-07-01)

Project Communication for Successfull Product Development : Developing a Project Overview at ITT W&WW
by: Lundberg, Emma, et al.
Published: (2011)

Careful consideration when responding to new data: dolutegravir and pregnancy
by: C. Foster, et al.
Published: (2018-07-01)

The role of dolutegravir in the management of HIV infections
by: Miller MM, et al.
Published: (2015-02-01)

Enhanced Eryptosis Following Exposure to Dolutegravir
by: Abdulla Al Mamun Bhuyan, et al.
Published: (2016-07-01)

DOLUTEGRAVIR efficacy in HIV infected patients
by: Dumitru Irina Magdalena, et al.
Published: (2015-02-01)

Pathogenicity of CD16+ monocyte-derived dendritic cells during HIV-1 infection
by: V.S. Wacleche, et al.
Published: (2015-12-01)

Ex Vivo Restimulation of Human PBMC Expands a CD3+CD4-CD8-γδ+ T Cell Population That Can Confound the Evaluation of CD4 and CD8 T Cell Responses to Vaccination
by: B. J. Sedgmen, et al.
Published: (2013-01-01)

Impairment of the long-term ability of dolutegravir-resistant viruses to integrate
by: M.A. Wainberg, et al.
Published: (2015-12-01)

SPECTROSCOPIC STUDY OF INTERACTION OF SODIUM DOLUTEGRAVIR WITH HUMAN SERUM ALBUMIN
by: A. V. Yegorova, et al.
Published: (2017-11-01)

An individual study base on interactive Diamond Model researches in maintaining the long-term effectiveness of E-Business after implementing ERP successfull
by: JHIH-JHONG CHENG, et al.
Published: (2014)

Creation of a long-acting nanoformulated dolutegravir
by: Brady Sillman, et al.
Published: (2018-02-01)

Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
by: Taha H, et al.
Published: (2015-10-01)

Suicidal overdose of dolutegravir: A case report
by: Rahul Daimari, et al.
Published: (2018-06-01)

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
by: Dowers E, et al.
Published: (2018-11-01)

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study
by: Anthony M. Mills, et al.
Published: (2019-11-01)

Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center.
by: Pierre Gantner, et al.
Published: (2015-01-01)

CD4+, CD8+ and CD4- CD8- T cell-subsets can confer protection against Leishmania m. mexicana infection
by: C. M Lezama-Dávila, et al.
Published: (1995-02-01)

A study of Schottky barriers to CdS, and the CdTe : CdS heterojunction
by: Forsyth, Nicola M.
Published: (1989)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger M, et al.
Published: (2009-03-01)

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
by: Zamora FJ, et al.
Published: (2019-10-01)

Potential benefit of dolutegravir once daily: efficacy and safety
by: Fantauzzi A, et al.
Published: (2013-02-01)

Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
by: Ana Pelufo-Pellicer, et al.
Published: (2017-03-01)

HIV–1 resistance to dolutegravir: update and new insights
by: Mark A. Wainberg, et al.
Published: (2015-01-01)

O papel do dolutegravir na terapia antiretroviral
by: Tamyres dos Santos Vieira, et al.
Published: (2019-06-01)

Extensive Proliferation of Cd4+ Lymphocyte by Both Phytohaemagglutinin A and Anti-Cd2/Cd3/ Cd28 Macsibeads
by: Mirzakhani M., et al.
Published: (2018-03-01)

CD44-dependent hyaluronan-binding and T-lymphocyte migration
by: Mohseni Koochesfahani, Kasra
Published: (2009)

CD44-dependent hyaluronan-binding and T-lymphocyte migration
by: Mohseni Koochesfahani, Kasra
Published: (2009)

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study
by: Rosario Palacios MD, PhD, et al.
Published: (2018-03-01)

Changes in Reactivity In Vitro of CD4+CD25+ and CD4+CD25− T Cell Subsets in Transplant Tolerance
by: Bruce M. Hall, et al.
Published: (2017-08-01)

TiO2-CdS Nanocomposites: Effect of CdS Oxidation on the Photocatalytic Activity
by: A. Hamdi, et al.
Published: (2016-01-01)

Color Tuning and White Light by Dispersing CdSe, CdTe, and CdS in PMMA Nanocomposite Waveguides
by: H. Gordillo, et al.
Published: (2013-01-01)

OA1-2 Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
by: G.E. Martin, et al.
Published: (2017-07-01)

Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations
by: Cruciani M, et al.
Published: (2015-02-01)

Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect
by: Reuben Granich, et al.
Published: (2018-05-01)

Cannot write session to /tmp/vufind_sessions/sess_h9nlk92ossr940dlfd4c46ep4o